immunotherapy drug made by Bristol-Myers Squibb. The drug maker funded the trial.b works by blocking cancer cells' ability to evade detection by the immune system, allowing immune cells to attack and kill the cancer.have a tumor that can be removed through surgery, researchers said in background notes.
Patients randomly were assigned to receive nivolumab before and after surgery along with pre-surgical chemo, or pre-surgery chemo only. But people who received nivolumab hadn't reached an average event-free survival time by the end of follow-up, meaning that it was prolonged significantly over the control group, researchers said.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
This time, it's personal: Enhancing patient response to cancer immunotherapyScientists uncover why cancer patients with ARID1A gene mutations are more likely to respond to immunotherapy, discovering ARID1A mutations invite cancer-fighting immune cells into tumors by triggering an antiviral-like response.
Source: ScienceDaily - 🏆 452. / 53 Read more »
Can Vitamin D Improve Cancer Immunotherapy?I am a scientist, businessman, author, and philanthropist. For nearly two decades, I was a professor at Harvard Medical School and Harvard School of Public Health where I founded two academic research departments, the Division of Biochemical Pharmacology and the Division of Human Retrovirology.
Source: ForbesTech - 🏆 318. / 59 Read more »
Pan-cancer analysis uncovers a new class of promising CAR T--cell immunotherapy targetsSt. Jude found 156 potential targets for chimeric antigen receptor (CAR) T--cell immunotherapy. Explore the discovery's promise to improve cancer therapies.
Source: ScienceDaily - 🏆 452. / 53 Read more »
Difference found in pancreatic cancer cells, offering new hope for immunotherapy effectivenessA new study has found that pancreatic cancer cells are different based on their location in the pancreas, providing new information about tumors that could lead to better targeted treatments.
Source: ScienceDaily - 🏆 452. / 53 Read more »
Component of keto diet plus immunotherapy may reduce prostate cancerAdding a pre-ketone supplement -- a component of a high-fat, low-carb ketogenic diet -- to a type of cancer therapy in a laboratory setting was highly effective for treating prostate cancer, researchers found.
Source: ScienceDaily - 🏆 452. / 53 Read more »